Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation

  • Technology appraisal guidance
  • TA311
  • Published: 

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence